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As their name suggests, pregnancy-related proteins were discovered through 
comparative examinations of pregnant and nonpregnant samples. Of the 
placental hormones and enzymes, human chorionic gonadotropin (hCG), 
human placental lactogen (hPL) and heat-stable alkaline phosphatase have 
been known for several decades. Since the '70's the number of these 
pregnancy-related proteins has grown steadily. In addition to three fetal and 
seven pregnancy proteins, Hans Bohn has isolated 20 solubilized or 
membrane associated placental proteins (MPs) and 26 soluble placental tissue 
proteins (PPs). 
Women’s Clinic and jointly  Institute of Biochemistry and Medical 
Chemistry of the University of Pécs has been involved in the collaboration 
research of the pregnancy-related oncofetal proteins for thirty years. During 
the years of collaboration the team has performed the isolation, and the basic 
and applied research study in normal and pathologic circumstances of 9 
novel proteins, and developed new measuring procedures. Since 1997 the 
team have been dealing with the sequential, structural, functional and 
expressional analyses of 8 placental proteins (PP13, PP17a, PP17b, PP18a, 
PP18b, PP20, PP23 and PP25) with genomical and proteomical methods. 
The research group discovered the PP17 protein family at the millennium. 
Two members of the protein family could be cloned and sequenced (PP17a: 
GenBank Accession No. AF051314, AF051315; PP17b: GenBank 
Accession No. AF055574; PP17c and PP17d). The team have started the 
functional analysis  of the PP17 protein family. The PP20 protein was not 
identified before, we knew only slightly more than a decade. PP20 is 
composed of two identical 27 kDa subunits. The carbohydrate content of 
PP20 was found to be relatively low (3.0% by weight) and the average 
amount of PP20 present in one human term placenta was found to be 0.5 mg. 
Study objectives 
 
1. Databank  search to reveal the expression, structure and regulation  
of the PP17 gene. Multiple sequence alignment, to prove to be a 
member of the growing lipid storage droplet protein family. 
 
2. Immunofluorescence microscopy and protein sequencing to 
present the evidence for the association of PP17b to lipid droplets 
and milk lipid globule membranes. 
 
3. Using a HeLa cell model to show the importance of protein kinase 
A and protein kinase C dependent pathways for the regulation of 
PP17 gene expression, and the effect of the phase of cell cycle, 
differentiation and apoptosis on expression of this gene. 
 
4. Isolation  of the cDNA of PP20 and analysis of the nucleotide and 
deduced amino acid sequences. 
 
5. Databank search to demonstrate the genomic localization, structure 
and regulation of PP20 gene 
 
6. Identification of PP20 by  mass spectrometry 
 
7. Analysis of PP20 / hTPK1 enzymatic activity by using HPLC-MS 
with electrospray (ESI) ionisation 
 
8. Expression and localization of PP20  
 







1. GenBank analysis of EST clones underlines that alternatively 
spliced PP17a occurs mainly in steroidogenic tissues, while PP17b 
is synthesized in almost all types of tissue, especially in placenta 
and epithelial origin tumors.  
 
2. Sequence data show high level sequence similarity at their N-
termini between PP17b and neutral lipid droplet associated 
proteins including perilipins and adipophilin, which latter was also 
involved in adipose cell differentiation. Taken altogether, a 
comparison of PP17b and its gene to perilipins and adipophilin, 
members of the “PAT domain gene family,” similar exon 
structures, sequence homology and many common transcription 
factor regulatory sequences in the promoter regions were found, 
suggesting their common genetic origin and functional similarities. 
 
3. With different techniques based on immunological reactions, 
considerable evidence was obtained to the effect that PP17b/TIP47 
was a neutral lipid droplet associated protein, which also occurs in 
significant quantities in milk lipid globule membranes. Because of 
the controversy in the literature on its function, to avoid possible 
immunological cross-reactivity, a very specific independent 
technique, MALDI-TOF MS analysis was used, and both PP17 
variants – PP17b most markedly – were proved to bind to the 
surface of neutral lipid droplets. Furthermore, our previous data 
showed that both PP17a and PP17b could aggregate even in the 
presence of low concentrations of SDS, raising the possibility that 
these proteins could be involved in the formation of different-size 
lipid droplets. By binding to lipid micelles and having self-
aggregating properties, PP17 variants could facilitate lipid droplet 
aggregation, which is clearly detectable in the case of milk lipid 
globule membranes. This property of PP17b indicates its function 
as a neutral lipid droplet associated protein and its involvement in 
lipid droplet formation/mobilization, in accordance with its 
possible function in cell and tissue differentiation. 
 
4. With computer analysis of its 5’ up-stream sequence, several 
transcription factor binding sites were identified, including mostly 
proliferation and / or apoptosis regulators, embryo- and 
organogenic factors, proto-oncogenes or their targets, which also 
points to the possible complex PP17 gene regulation.  
 
 
5. Induction of apoptosis and differentiation indeed up-regulated 
PP17 expression, while kinase cascade inhibition led to a 
transcription factor activation block on the induction of PP17 
expression, providing evidence for the importance of those 
transcription factors in PP17 gene regulation. These data also 
indicate that PP17b could play an important role in tumor cell 
development and differentiation. Since providing rich lipid supply 
to cells induced lipid droplet formation and PP17b overexpression, 
this indicates that PPARγ could have a role in the regulation of 
PP17 expression. Furthermore, these data suggest that the main 
function of PP17a and PP17b is involvement in lipid droplet 
formation and in rearrangement of lipid membranes, which 
processes could also be important in cell differentiation and 
division. The high concentration of PP17b in milk lipid globule 
membranes indicates its potential role in exporting lipid droplets 
and membranes. 
 
6. In the case of several previously known “placental proteins,” 
which turned out to have a general function in different human 
tissues, more specific structural or functional names were given, 
such as galectin-13 (PP13), glycodelin (PP14) or branched-chain 
aminotransferase (PP18). As (1) PP17b is synthesized 
ubiquitously, while PP17a is found mainly in steroidogenic 
tissues; (2) both PP17 variants are generally involved in lipid 
droplet formation, like alternatively spliced perilipins, which were 
shown to bind either to steroid or neutral lipid droplets; (3) neither 
the name “placental protein 17b (PP17b)” nor “tail-interacting 
protein of 47 kDa (TIP47)” gives the appropriate information on 
the structure, function, regulation, or the origin of this protein; (4) 
there is still a lack of an official name for the “PP17/TIP47” gene; 
and (5) there is a common need to elucidate this controversial 
situation, it is therefore now proposed that the PP17 variants be 
renamed to sandrin A (PP17a) and sandrin B (PP17b) (Steroid 
And Neutral lipid DRoplet-associated proteIN), and their gene to 
SNDR. 
 
7. Four cDNAs have been isolated from placental library encoding 
the 243 residue-long  protein, having two variants (27 kDa and 54 
kDa).The 54 kDa variant was verified to be a dimer. By its 
primary nucleotide sequence, PP20 proved to be identical to 
human thiamin pyrophosphokinase (hTPK), as confirmed by 
protein sequence analysis.  
 
8. GenBank search information revealed PP20 / hTPK gene was 
located on chromosome 7q34-q36 and was predominantly 
expressed in the placenta. The genomic sequence contained 9 
exons, not 8 as published previously when the exon division and 
5’-upstream region of the gene were not yet resolved 
 
9. Analysis of the 1kb promoter region showed numerous putative 
transcription factor binding sites, which might be responsible for 
the ubiquitous PP20 / hTPK expression. This may also be in 
accordance with the presence of the protein in tissues responsible 
for the regulation of the exquisite balance between cell division, 
differentiation and survival. 
 
10. TPK activity of the purified and recombinant protein was proved 
by mass spectrometry. 
 
11. PP20 / hTPK was found in all human normal and tumorous adult 
and fetal tissues in nearly equal amounts, but not in sera.  
 
12. By immunohistochemical and immunofluorescent confocal 
imaging methods, diffuse labelling in the cytoplasm of the 
syncytiotrophoblasts and weak staining of the trophoblasts were 
observed, and the amount of PP20 / hTPK decreased from the first 
trimester to the end of gestation. 
 
13. A 3D model of PP20 / hTPK was computed (PDB No: 1OLY) by 
homology modelling. A high degree of structural homology 
showed that thiamin binding-site was highly similar to that of 
mouse enzyme, but highly different from the bacterial ones. 
Comparison of the catalytic centre sequences revealed differences, 
raising the possibility of designing new drugs which specifically 
inhibit bacterial and fungal enzymes without affecting PP20 / 





















Fig.  3D homology modelling and sequence alignment of PP20 / hTPK to 
mouse TPK. (A) Identical residues in PP20 / hTPK and mouse TPK were 
shaded dark grey, conservative changes in light grey, the thiamin binding 
site in red and the suspected ATP binding site in blue. (B) 3D model of the 
PP20 / hTPK homodimer enzyme was constructed by homology modelling 
with MOLSCRIPT [20] based on the mTPK crystal structure. The 3D model 
was rendered by Raster3D. The peptide backbones were represented as 
ribbons, the thiamin binding-sites as balls and sticks, and thiamins as 
spacefills. 
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